As part of a multi-stream project for a global leader in the CGT industry, this project was undertaken to understand the latest trends and insights into the future direction of the Regenerative Medicine market.
GlobalData was commissioned to support a leading provider of healthcare technologies and services. The main objective was to help the client understand the current trends in CGT use and future potential uptake. The insights were used to guide our clients strategic direction across the US, Europen and APAC markets.
Our Solution
GlobalData conducted 15 qualitative key opinion leader (KOL) interviews across the US, 5EU, China and Japan in order to examine the latest insights on the CGT market, the current use of therapies in oncology and assess upcoming pipeline candidates and their future potential in the market. This intelligence was delivered alongside the additional workstreams and helped to validate forecasting assumptions across multiple indications.
Outcome
GlobalData presented the findings in a comprehensive yet concise report, and streamlined the client’s workflow by integrating all data captured into the client’s internal templates. The insightful outputs were used to guide our client’s strategic direction across the US, European and APAC markets.
Our consultants work closely with you to understand requirements and develop a tailored approach and deliverables.
